A Pilot Study of Eribulin in Breast Cancer (BC) Patients With Brain Metastases Previously Treated With Anthracyclines and Taxanes

NCT03412955 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Eribulin Mesylate

Sponsor

Tan Tock Seng Hospital